TD Cowen Maintains Buy on Alkermes, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 69.3%

Neg 0% Neu 0% Pos 69.3%

TD Cowen analyst Joseph Thome maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $42 to $50.

Comments

No comments yet. Be the first!